Intersubjectivity, affective neuroscience, and the neurobiology of autistic spectrum disorders: A systematic review

Keio Journal of Medicine

Volumn 57, Issue 1, 2008, Pages 15-36

  Aitken, Kenneth J ^a,b  

^a NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

Autistic spectrum disorder; Fragile X; Gamma amino butyric acid; Glutamate; Intersubjectivity; Intrinsic motive formation; Mirror neuron; Misoprostal; Sodium valproate; Sterol; Thalidomide; Tryptophan; Vitamin B12

Indexed keywords

4 AMINOBUTYRIC ACID; COBALT; CYANOCOBALAMIN; GLUTAMIC ACID;

AUTISM; COMMUNICATION SKILL; DISEASE COURSE; EMOTION; FRAGILE X SYNDROME; HEREDITY; HUMAN; METHYLMALONIC ACIDEMIA; MOTOR DEVELOPMENT; NERVE CELL; NEUROBIOLOGY; OUTCOME ASSESSMENT; PATHOGENESIS; PERCEPTION; PREVALENCE; REVIEW; SOCIAL EVOLUTION; SOCIAL INTERACTION; STEROL METABOLISM; SYSTEMATIC REVIEW; TERATOGENICITY; TRYPTOPHAN METABOLISM; VIRUS INFECTION;

AFFECT; AUTISTIC DISORDER; COGNITION; HUMANS;

EID: 44349085459     PISSN: 00229717     EISSN: 18801293     Source Type: Journal    
DOI: 10.2302/kjm.57.15     Document Type: Review

References (263)

1. Gupta A.R. & State M.W: Advances in the Genetics of Autism, Biol.Psychiatry 2006: doi:10.1016/j.biopsych.2006.06.020; 2007; 61: 429-443.
2. Junaid M.A. & Pullarkat R.K. Proteomic approach for the elucidation of biological defects in autism. J Aut Dev Disorders 2001; 31: 557-560
3. Rohlff C. & Hollis K. Modern Proteomic Strategies in the Study of Complex Neuro-Psychiatric Disorders, Biol Psychiatry 2003; 53: 847-853.
4. http://www.greenelab.columbia.edu/
5. Newschaffer C.J. Fallin D. & Lee N.L. Heritable and Nonheritable Risk Factors for Autism Spectrum Disorders. Epidemiologic Reviews 2002; 24: 137-153.
6. Herbert M.R. Russo J.P. Yang S. Roohi J. Blaxill M. Kahler S.G. Cremer L. & Hatchwell E. Autism and environmental genomics. NeuroToxicology 2006; 27: 671-684.
7. Shore S.M. & Rastelli L.G. Understanding Autism for Dummies. 2006: Wiley Publishing Inc.: Hoboken.
8. Shavelle R.M. Strauss D.J. & Pickett J. Causes of death in autism. J Autism Dev Disord, 2001; 31: 569-576.
9. Gerlai J. & Gerlai R. Autism: a large unmet medical need and a complex research problem. Physiol Behav, 2003; 79: 461-470.
10. Happe F. Ronald A. & Plomin R. Time to give up on a single explanation for autism. Nature Neurosci, 2006; 9: 1218-1220.
11. Ronald A. Happe F. Bolton P. Butcher L.M. Price T.S. Wheelwright S. Baron-Cohen S. & Plomin R. Genetic Heterogeneity Between the Three Components of the Autism Spectrum: A Twin Study. J Am Acad Child Adolesc Psychiatry, 2006; 45: 691-699.
12. Lam K.S.L., Aman M.G. & Arnold E. Neurochemical correlates of autistic disorder: A review of the literature. Research in Developmental Disabilities, 2005; 27: 254-289.
13. Moran C.N. Scott R.A. Adams S.M. Warrington S.J. Jobling M.A. Wilson R.H. Goodwin W.H. Georgiades E. Wolde B. & Pitsiladis Y.P. Y chromosome haplotypes of elite Ethiopian endurance runners, Hum Genet, 2004; 115: 492-497.
14. Leung P.W. Lee C.C. Hung S.F. Ho T.P. Tang C.P. Kwong S.L. Leung S.Y. Yuen S.T. Lieh-Mak F. Oosterlaan J. Grady D. Harxhi A. Ding Y.C. Chi H.C. Flodman P. Schuck S. Spence M.A. Moyzis R. & Swanson J. Dopamine receptor D4 (DRD4) gene in Han Chinese children with atten-tion-deficit/hyperactivity disorder (ADHD): increased prevalence of the 2-repeat allele. Am J Med Genet B Neuropsychiatr Genet, 2005; 133: 54-56.
15. D'Amelio M. Ricci I. Sacco R. Liu X. D'Agruma L. Muscarella L.A. Guarnieri V. Militerni R. Bravaccio C. Elia M. Schneider C. Melmed R. Trillo S. Pascucci T. Puglisi-Allegra S. Reichelt K.L. Macciardi F. Holden J.J. & Persico A.M. Paraoxonase gene variants are associated with autism in North America, but not in Italy: possible regional specificity in gene-environment interactions. Mol Psychiatry, 2005; 10: 1006-1016.
16. Koishi S. Yamamoto K. Matsumoto H. Enseki Y. Oya A. Asakura A. Aoki Y. Atsumi M. Iga T. Inomata J. Inoko H. Sasaki T. Nanba E. Kato N. Ishii T. & Yamazaki K. Serotonin transporter gene promoter polymorphism and autism: A family-based genetic association study in Japanese population. Brain Dev, 2006; 28: 257-260.
17. Yonan A.L. Alarcon M. Cheng R. Magnusson P.K. Spence S.J. Palmer A.A. Grunn A. Juo S.H. Terwilliger J.D. Liu J. Cantor R.M. Geschwind D.H. & Gilliam T.C. A genomewide screen of 345 families for autism-susceptibility loci. Am J Hum Genet, 2003; 73: 886-897.
18. Winnicott D. Mirror-Role of Mother and Family in Child Development. in: Playing and Reality, 1971; London: Tavistock Press.
19. Panksepp J. A critical role for "affective neuroscience" in resolving what is basic about basic emotions. Psychol Rev, 1992; 99: 554-560.
20. Cacioppo J.T. Visser P.S. & Pickett C.L. (Eds.) Social Neuroscience: People thinking about thinking people. 2006: Massachusetts: MIT Press.
21. Cole P.M. Martin S.E. & Dennis T.A. Emotion Regulation as a Scientific Construct: Methodological Challenges and Directions for Child Development Research. Child Dev, 2004; 75: 317-333.
22. Rutter M. & Casaer P. (Eds.) Biological Risk Factors for Psychosocial Disorders. 1991: Cambridge: Cambridge University Press.
23. Cicchetti D. & Cohen D.J. (Eds.) Developmental Neuroscience, Vol.2 of: Developmental Psychopathology. 2006: (2nd Edn.), Hoboken, New Jersey: John Wiley & Sons.
24. Trevarthen C. Aitken K.J. Vandekerckhove M. Delafield-Butt J. & Nagy E. Collaborative Regulations of Vitality in Early Childhood: Stress in Intimate Relationships and Postnatal Psychopathology. in: Cichetti D. & Cohen D.J. (Eds.) Developmental Psychopathology, 2006; Vol.2, Ch.1, John Wiley.
25. Hartsoeker N. Essay de Dioptrique, 1694: Paris : Jean Anison.
26. Trevarthen C. & Aitken K.J. Infant intersubjectivity: Research, theory, and clinical applications. Annual Research Review. J Child Psychol Psychiatry; 2001; 42: 3-48.
27. Legerstee M. Infants' Sense of People: Precursors to a Theory of Mind. 2005: Cambridge: Cambridge University Press.
28. Tiedemann H. Beobachtungen uber die entwicklung die Seelenfahrigkeiten bei kindern. Hessichen Beitrage zur Gelehrsamskeit und Kunst, 1787; 2: pp313ff 383ff.
29. Als H. Tronick E. & Brazelton T.B. Affective reciprocity and the development of autonomy: the study of a blind infant. J Am Acad Child Psychiatry, 1980; 19: 22-40.
30. Greenough W.T. Black J.E. & Wallace C.S. Experience and Brain Development. Child Dev. 1987; 58: 539-559.
31. Als H. Duffy F.H. McAnulty G.B. Rivkin M.J. Vajapeyam S. Mulkern R.V. Warfield S.K. Huppi P.S. Butler S.C Conneman N. Fischer C. & Eichenwald E.C. Early experience alters brain function and structure. Pediatrics, 2004; 113: 846-857.
32. Johnson M.H. & Munakata Y. Processes of change in brain and cognitive development. Trends Cog Sci, 2005; 9: 152-158.
33. Dawson G. Ashman S.B. & Carver L.J. The role of early experience in shaping behavioral and brain development and its implications for social policy. Dev Psychopathol 2000; 12: 695-712.
34. Shonkoff J.P. & Phillips D.A. (Eds.) From Neurons to Neighborhoods: The Science of Early Childhood Development. 2000: National Academy Press: Washington.
35. Trevarthen C. & Aitken K.J. Regulation of brain development and age-related changes in infants' motives: The developmental function of 'regressive' periods. In: Regression Periods in Human Infancy. Heimann M. & Plooij F. (eds.) 2003: Mahwah, NJ: Erlbaum, pp. 107-184.
36. Rizzolatti G. & Craighero L. The mirror neuron system. Annu Rev Neurosci,2004; 27: 169-192.
37. Northoff G. Heinzel A. de Greck M. Bermpohl F. Dobrothwolny H. & Panksepp J. Self-referential processing in our brain - A meta-analysis of imaging studies on the self. Neuroimage, 2006; 31: 440-457.
38. Jackson P.L. Meltzoff A.N. & Decety J. Neural circuits involved in imitation and perspective-taking. Neuroimage, 2006; 31: 429-439.
39. Iacoboni M. Molnar-Szakacs I. Gallese V. Buccino G. Mazziotta J.C. & Rizzolatti G. Grasping the Intentions of Others with One's Own Mirror System. PLOS Biology, 2005; 3: e79.
40. Vollm B.A. Taylor A.N.W. Richardson P. Corcoran R. Stirling J. McKie S. Deakin J.F.W. & Elliott R. Neuronal correlates of theory of mind and empathy: A functional magnetic resonance imaging study in a nonverbal task. Neuroimage, 2005; 29: 90-98.
41. Aitken K.J. & Trevarthen C. Self/other organization in human psychological development. Dev Psychopathol 1997; 9: 653-677.
42. Trevarthen C. & Aitken K.J. Brain development, infant communication, and empathy disorders: intrinsic factors in child mental health. Dev Psychopathol 1994; 6: 597-633.
43. McLean P.D. Triune brain. In G. Edelman & B.H. Smith (Eds.), Encyclopedia of Neurosci-ence 3rd Ed. (Article 203). 2004: Amsterdam: Elsevier Science.
44. Holstege G. Bandler R. & Saper C.B. (Eds.) The emotional motor system. 1996: Amsterdam: Elsevier.
45. Panksepp J. Affective neuroscience: The foundations of human and animal emotions. 1998: New York: Oxford University Press.
46. Panksepp J. The periconscious substrates of consciousness: Affective states and the evolutionary origins of the SELF. Journal of Consciousness Studies, 1998; 5: 566-582.
47. Kanner L. Autistic disturbances of affective contact. Nervous Child, 1943; 2: 217-250.
48. Rutter M.L. Kreppner J.M. & O'Connor T.G. Specificity and heterogeneity in children's responses to profound institutional privation. Br J Psychiatry, 2001; 179: 97-103.
49. Hoksbergen R. ter Laak J. Rijk K. van Dijkum C. & Stoutjesdijk F. Post-Institutional Autistic Syndrome in Romanian adoptees. J Autism Dev Disord, 2005; 35: 615-623.
50. Lord C. & Luyster R. Early diagnosis of children with autism spectrum disorders. Clinical Neuroscience Research, 2006: doi:10.1016/j.cnr.2006.06.005.
51. Aitken K.J. Diagnostic issues in autism - are we measuring the emperor for another suit of clothes ? Dev Med Child Neurol; 1991; 133: 1015-1020.
52. Trevarthen C. Aitken K.J. Papoudi D. & Robarts J. Children with Autism (2nd Edn.). 2005 (Japanese Translation).
53. Risi S. Lord C. Gotham K. Corsello C. Chrysler C. Szatmari P. Cook E.H.Jr. Leventhal B.L. & Pick-les A. Combining information from multiple sources in the diagnosis of autism spectrum disorders. J Am Acad Child Adolesc Psychiatry, 2006; 45: 1094-1103.
54. Wing L. Leekam S.R. Libby S.J. Gould J. & Larcombe M. The Diagnostic Interview for Social and Communication Disorders: background, inter-rater reliability and clinical use. J Child Psychol Psychiat, 2002; 43: 307-325.
55. Glasson E.J. Bower C. Petterson B. de Klerk N. Chaney G. & Hallmeyer J.F. Perinatal factors and the development of autism: a population study. Arch Gen Psychiatry, 2004; 61: 618-627.
56. Dementieva Y.A. Vance D.D. Donnelly S.L. Elston L.A. Wolpert C.M. Ravan S.A. DeLong G.R. Abramson R.K. Wright H.H. & Cuccaro M.L. Accelerated head growth in early development of individuals with autism. Pediatr Neurol, 2005; 32: 102-108.
57. Conciatori M. Stodgell C.J. Hyman S.L. O'Bara M. Militerni R. Bravaccio C. Trillo S. Montecchi F. Schneider C. Melmed R. Elia M. Crawford L. Spence S.J. Muscarella L. Guarnieri V. D'Agruma L. Quattrone A. Zelante L. Rabinowitz D. Pascucci T. Puglisi-Allegra S. Reichelt K-L. Rodier P.M. & Persico A.M. Association between the HOXA1 A218G Polymorphism and Increased Head Circumference in Patients with Autism. Biol Psychiatry; 2004; 55: 413-441.
58. Molloy C.A. Morrow A.L. Meinzen-Derr J. Dawson G. Bernier R. Dunn M. Hyman S.L. McMahon W.M. Goudie-Nice J. Hepburn S. Minshew N. Rogers S. Sigman M. Spence M.A. Tager-Flusberg H. Volkmar F.R. & Lord C. Familial Autoimmune Thyroid Disease as a Risk Factor for Regres-sion in Children with Autism Spectrum Disorder: A CPEA Study. J Aut Dev Disord, 2006, 36 (3): 317-24
59. Szpir M. Tracing the Origins of Autism: A Spectrum of New Studies. Environmental Health Perspectives, 2006; 114: A412-A418.
60. Hertz-Picciotto I. Croen L.A. Hansen R. Jones C.R. van de Water J.& Pessah I.N. The CHARGE study: An Epidemiologic Investigation of Genetic and Environmental Factors Contributing to Autism. Environmental Health Perspectives, 2006; 114: 1119-1125.
61. Teitelbaum P. Teitelbaum O. Nye J. Fryman J. & Maurer R.G. Movement analysis in infancy may be useful for early diagnosis of autism. Proc Natl Acad Sci U S A, 1998; 95: 13982-13987.
62. McGraw M.B. The Neuromuscular Maturation of the Human Infant. 1943: New York: Hagner.
63. Adrien J.L. Perrot A. Sauvage D. Leddet I. Larmande C. Hameury L. & Barthelemy C. Early symptoms in autism from family home movies. Evaluation and comparison between 1st and 2nd year of life using I.B.S.E. scale. Acta Paedopsychiatr, 1992; 55: 71-75.
64. Osterling J. & Dawson G. Variation in early developmental course in autism and its relation with behavioral outcome at 3-4 years of age. J Aut Dev Disord, 1994; 24: 247-259.
65. Werner E. Dawson G. Munson J. & Osterling J. Variation in early developmental course in au-tism and its relation with behavioral outcome at 3-4 years of age. J Autism Dev Disord, 2005; 35: 337-350.
66. Maestro S. Muratori F. Cesari A. Cavallaro M.C. Paziente A. Pecini C. Grassi C, Manfredi A. & Sommario C. Course of autism signs in the first year of life. Psychopathology, 2005; 38: 26-31.
67. Aitken K.J. Examining the evidence for a common structural basis to autism. Dev Med Child Neurol; 1991; 33: 930-934.
68. Penn H.E. Neurobiological correlates of autism: a review of recent research. Neuropsychol Dev Cogn C Child Neuropsychol, 2006; 12: 57-79.
69. Schumann C.M. & Amaral D.G. Stereological analysis of amygdala neuron number in autism. J Neurosci, 2006; 26: 7674-7679.
70. Salmond C.H. Ashburner J. Connelly A. Friston K.J. Gadian D.G. & Vargha-Khadem F. The role of the medial temporal lobe in autistic spectrum disorders. Eur J Neurosci, 2005; 22: 764-772.
71. Bauman M.L. & Kemper T.L. Neuroanatomic observations of the brain in autism: a review and future directions. Int J Dev Neurosci, 2005; 23: 183-187.
72. Nicolson R. DeVito T.J. Vidal C.N. Sui Y. Hayashi K.M. Drost D.J. Williamson P.C. Rajakumara N. Toga A.W. & Thompson P.M. Detection and mapping of hippocampal abnormalities in autism. Psychiatry Research: Neuroimaging, 2006; 148: 11-21.
73. Courchesne E. Yeung-Courchesne R. Press G.A. Hesselink J.R. & Jernigan, T.L. Hypoplasia of cerebellar vermal lobules VI and VII in autism. N Eng J Med, 1988; 318: 1349-1354.
74. Courchesne E. Saitoh O. Townsend J.P. Yeung-Courchesne R. Press G.A. Lincoln A.J. Haas R.H. & Schriebman L. Cerebellar hypoplasia and hyperplasia in infantile autism. Lancet, 1994; 343: 63-64.
75. Fatemi S.H. Halt A.R. Realmuto G. Earle J. Kist D.A. Thuras P. & Merz A. Purkinje cell size is reduced in cerebellum of patients with autism. Cell Mol Neurobiol, 2002; 22: 171-175.
76. Skoyles J.R. Is autism due to cerebral-cerebellum disconnection ? Med Hypotheses, 2002;58: 332-336.
77. Huber K.M. The fragile X-cerebellum connection. TINS, 2006; 29: 183-185.
78. Schmahmann J.D. & Sherman J.C. The cerebellar cognitive affective syndrome. Brain, 1998; 121: 561-579.
79. Courchesne E. Redcay E. & Kennedy D.P. The autistic brain: birth through adulthood. Curr Opin Neurol, 2004;17: 489-496.
80. McCaffery P. & Deutsch C.K. Macrocephaly and the control of brain growth in autistic disorders. Prog Neurobiol, 2005; 77: 38-56.
81. Just M.A. Cherkassky V.L. Keller T.A. Kana R.K. & Minshew N.J. Functional and anatomical cortical underconnectivity in autism: Evidence from an fMRI study of an executive function task and corpus callosum morphometry. Cerebral Cortex, 2006; doi:10.1093/cerco/bh1006.
82. Bachevalier J. & Loveland K.A. The orbitofrontal-amygdala circuit and self-regulation of social-emotional behavior in autism. Neurosci Biobehav Rev, 2006; 30: 97-117.
83. Haznedar M.M. Buchsbaum M.S. Hazlett E.A. LiCalzi E.M. Cartwright C. & Hollander E.Volumetric analysis and three-dimensional glucose metabolic mapping of the striatum and thalamus in patients with autism spectrum disorders. Am J Psychiatry, 2006; 163: 1252-1263.
84. Harris G.J. Chabris C.F. Clark J. Urban T. Aharon I. Steele S. McGrath L. Condouris K. & Tager-Flusberg, H. Brain activation during semantic processing in autism spectrum disorders via functional magnetic resonance imaging. Brain and Cognition, 2006; 61: 54-68.
85. Grelotti D.J. Klin A.J. Gauthier I. Skudlarski P. Cohen D.J. Gore J.C. Volkmar F.R. & Schultz R.T. fMRI activation of the fusiform gyrus and amygdala to cartoon characters but not to faces in a boy with autism. Neuropsychologia, 2005; 43: 373-385.
86. Baron-Cohen S. Allen J. & Gillberg C. Can autism be detected at 18 months? The needle, the haystack, and the CHAT. British Journal of Psychiatry, 1992; 138: 839-843.
87. Baird G. Charman T. Baron-Cohen S. Cox A. Swettenham J. Wheelwright S. & Drew A. A screening instrument for autism at 18 months of age: a 6-year follow-up study. J Am Acad Child Adolesc Psychiatry, 2000; 39: 694-702.
88. Robins D.L. Fein D. Barton M.L. & Green J.A. The Modified Checklist for Autism in Toddlers: an initial study investigating the early detection of autism and pervasive developmental disorders. J Autism Dev Disord, 2001; 31: 131-144.
89. Robins D.L. & Dumont-Mathieu T.M. Early Screening for Autism Spectrum Disorders: Update on the Modified Checklist for Autism in Toddlers and Other Measures. J Dev Behav Pediatr, 2006; 27: S111-S119.
90. Wong V. Hui L.H. Lee W.C. Leung L.S. Ho P.K. Lau W.L. Fung C.W. & Chung B. A modified screening tool for autism (Checklist for Autism in Toddlers [CHAT-23]) for Chinese children. Pediatrics, 2004; 114: e166-176.
91. Persson B. Nordstrom B. Petersson K. Mansson M.E. & Sivberg B. Screening for Infants With Developmental Deficits and/or Autism: A Swedish Pilot Study. Journal of Pediatric Nursing, 2006; 21: 313-324.
92. Williams J.H. Whiten A. Suddendorf T. & Perrett D.I. Imitation, mirror neurons and autism. Neurosci Biobehav Rev, 2001; 25: 287-295.
93. Hadjikhani N. Joseph R.M. Snyder J. & Tager-Flusberg H. Anatomical differences in the mirror neuron system and social cognition network in autism. Cerebral Cortex, 2006; 16: 1276-1282.
94. Avikainen S. Wohlschlager A. Liuhanen S. Hanninen R. & Hari R. Impaired mirror-image imitation in Asperger and high-functioning autistic subjects. Curr Biol, 2003; 13: 339-341.
95. Oberman L.M. Hubbard E.M. McCleery J.P. Altschuler E.L. Ramachandran V.S. & Pineda J.A. EEG evidence for mirror neuron dysfunction in autism spectrum disorders. Cognitive Brain Research, 2005; 24: 190-198.
96. Gallese V. Intentional attunement: A neurophysiological perspective on social cognition and its disruption in autism. Brain Research, 2006; 1079: 15-24.
97. Williams J.H.G. Gilchrist W.G.D. Perrett D.I. Murray A.D. & Whiten A. Neural mechanisms of imitation and 'mirror neuron' functioning in autistic spectrum disorder. Neuropsychologia, 2006; 44: 610-621.
98. Allman J. Hakeem A. & Watson K. Two Phylogenetic Specializations in the Human Brain. The Neuroscientist, 2002; 8: 335-346.
99. Allman J.M. Watson K.K. Tetreault N.A. & Hakeem A.Y. Intuition and autism: a possible role for Von Economo neurons. Trends Cogn Sci, 2005; 9: 367-373.
100. Charman T. The prevalence of autism spectrum disorders: Recent evidence and future challenges. European Child & Adolescent Psychiatry, 2002; 11: 249-256.
101. Fombonne E. Epidemiology of autistic disorder and other pervasive developmental disorders. J Clin Psychiatry, 2005; 66(Supp.10), 3-8.
102. Williams J.G. Higgins J.P. & Brayne C.E. Systematic review of prevalence studies of autism spectrum disorders. Arch Dis Child, 2006; 91: 8-15.
103. Grether J.K. Epidemiology of autism: Current controversies and research directions. Clinical Neuroscience Research, 2006: doi:10.1016/j.cnr.2006.06.009
104. Baird G. Simonoff E. Pickles A. Chandler S. Loucas T. Meldrum D. & Charman T. Prevalence of disorders in the autism spectrum in a population cohort of children in South Thames: the Special Neerds and Autism Project (SNAP). Lancet, 2006; 368: 210-215.
105. Honda H. Shimizu Y. & Rutter M. No effect of MMR withdrawal on the incidence of autism: a to-tal population study. Journal of Child Psychology and Psychiatry, 2005; 46: 572-579.
106. Howlin P. The effectiveness of interventions for children with autism. J Neural Transm Suppl, 2005; 69: 101-119.
107. Miniscalco C. Nygren G. Hagberg B. Kadesjo B. & Gillberg C. Neuropsychiatric and neurodevelopmental outcome of children at age 6 and 7 years who screened positive for language problems at 30 months. Dev Med Child Neurol, 2006; 48: 361-366.
108. Strauss D.J. Day S.M. Shavelle R.M. & Wu Y.W. Remote symptomatic epilepsy: does seizure severity increase mortality ? Neurology, 2003; 60: 395-399.
109. Bailey A. Le Couteur A. Gottesman I. Bolton P. Simonoff E. Yuzda E. & Rutter M. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med, 1995; 25: 63-77.
110. Steffenburg S. Gillberg C. Hellgren L. Andersson L. Gillberg I.C. Jakobsson G. & Bohman M. A twin study of autism in Denmark, Finland, Iceland, Norway and Sweden. J Child Psychol Psychiatry, 1989; 30: 405-416.
111. Hall J.G. Twinning: mechanisms and genetic implications. Curr Opin in Genetics and Dev, 1986; 6: 343-347.
112. Ho A. Todd R.D. & Constantino J.N. Brief report: autistic traits in twins vs. non-twins - a preliminary study. J Autism Dev Disord, 2005; 35: 129-133.
113. Betancur C. Leboyer M. & Gillberg C. Increased rate of twins among affected sibling pairs with autism. Am J Hum Genet 2002; 70: 1381-1383.
114. Hallmayer J. Glasson E.J. Bower C. Petterson B. Croen L. Grether J. & Risch N. On the twin risk in autism. Am J Hum Genet. 2002; 71: 941-946.
115. Croen L.A. Grether J.K. & Hallmayer J. Poster Presentation: 'A Population-Based Study of Autism Among Twins in California.' IMFAR, Orlando, Florida.
116. Aitken K.J. Behavioural Phenotypes in Developmental Psychopathology. Journal of Child Psychology and Psychiatry Occasional Papers Series, 1998; 15: 5-20.
117. Einfeld S.L. Behaviour phenotypes in genetic disorders. Curr Opin Psychiatry, 2004; 17: 343-348.
118. Cohen D. Pichard N. Tordjman S. Baumann C. Burglen L. Excoffier E. Lazar G. Mazet P. Pinquier C. Verloes A. & Heron D. Specific genetic disorders and autism: clinical contribution towards their identification. J Autism Dev Disord, 2005; 35: 103-116.
119. Herbert M.R. Russo J.P. Yang S. Roohi J. Blaxill M. Kahler S.G. Cremer L. & Hatchwell E. Au-tism and environmental genomics. NeuroToxicology, 2006; 27: 671-684.
120. Lamb J.A. Moore J. Bailey A. & Monaco A.P. Autism: recent molecular genetic advances. Hum Mol Genet, 2000; 9: 861-868.
121. Ashley-Koch A.E. Mei H. Jaworski J. Ma D.Q. Ritchie M.D. Menold M.M. Delong G.R. Abramson R.K. Wright H.H. Hussman J.P. Cuccaro M.L. Gilbert J.R. Martin E.R. & Pericak-Vance M.A. An analysis paradigm for investigating multi-locus effects in complex disease: examination of three GABA receptor subunit genes on 15q11-q13 as risk factors for autistic disorder. Ann Hum Genet, 2006; 70: 281-292.
122. Lander E. & Kruglyak L. Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results. Nat Genet, 1995; 11:241-247.
123. Auranen M. Vanhala R. Varilo T. Ayers K. Kempas E. Ylisaukko-Oja T. Sinsheimer J.S. Peltonen L. & Jarvela I. A genomewide screen for autism-spectrum disorders: Evidence for a major susceptibility locus on chromosome 3q25-27. Am J Hum Genet 2002; 71:777-790.
124. Ylisaukko-oja T. Nieminen-von Wendt T. Kempas E. Sarenius S. Varilo T. von Wendt L. Peltonen L. & Jarvela I. Genome-wide scan for loci of Asperger syndrome. Mol Psychiatry, 2004; 9:161-168.
125. Buxbaum J.D. Silverman J. Keddache M. Smith C.J. Hollander E. Ramoz N. & Reichert J.G. Linkage analysis for autism in a subset families with obsessive-compulsive behaviors: Evidence for an autism susceptibility gene on chromosome 1 and further support for susceptibility genes on chromosome 6 and 19. Mol Psychiatry 2004; 9:144-150.
126. International Molecular Genetic Study of Autism Consortium (2001): A genomewide screen for au-tism: Strong evidence for linkage to chromosomes 2q, 7q, and 16p. Am J Hum Genet, 2001; 69:570-581.
127. McCauley J.L. Li C. Jiang L. Olson L.M. Crockett G. Gainer K. Folstein S.E. Haines J.L. & Sutcliffe J.S. Genome-wide and Ordered-Subset linkage analyses provide support for autism loci on 17q and 19p with evidence of phenotypic and interlocus genetic correlates. BMC Med Genet 2005: 6:1-11. doi:10.1186/1471-2350-6-1
128. Alarcon M. Yonan A.L. Gilliam T.C. Cantor R.M. & Geschwind D.H. Quantitative genome scan and Ordered-Subsets Analysis of autism endophenotypes support language QTLs. Mol Psychiatry 2005; 10:747-757.
129. Liu J. Nyholt D.R. Magnussen P. Parano E. Pavone P. Geschwind D. Lord, C. Iversen P. Hoh J. Ott J.& Gilliam T.C. A genomewide screen for autism susceptibility loci. Am J Hum Genet 2001; 69: 327-340.
130. Philippe A. Martinez M. Guilloud-Bataille M. Gillberg C. Rastam M. Sponheim E. Coleman M. Zappella M. Aschauer H. Van Maldergem L. Penet C. Feingold J. Brice A..& Leboyer M. Genome-wide scan for autism susceptibility genes. Paris Autism Research International Sibpair Study. Hum Mol Genet, 1999; 8: 805-812.
131. Barrett S. Beck J.C. Bernier R. Bisson E. Braun T.A. Casavant T.L. Childress D. Folstein S.E. Garcia M. Gardiner M.B. Gilman S. Haines J.L. Hopkins K. Landa R. Meyer N.H. Mullane J.A. Nishimura D.Y. Palmer P. Piven J. Purdy J. Santangelo S.L. Searby C. Sheffield V. Singleton J. Slager S. Struchen T. Svenson S. Vieland V. Wang K. & Winklosky B. An autosomal genomic screen for autism. Collaborative linkage study of autism. Am J Med Genet, 1999; 88: 609-615.
132. International Molecular Genetic Study of Autism Consortium. A full genome screen for autism with evidence for linkage to a region on chromosome 7q. Hum Mol Genet 1998; 7:571-578.
133. Molloy C.A. Keddache M. & Martin L.J. Evidence for linkage on 21q and 7q in a subset of autism characterized by developmental regression. Mol Psychiatry 2005; 10:741-746.
134. Stone J.L. Merriman B. Cantor R.M. Yonan A.L. Gilliam T.C. Geschwind D.H. & Nelson S.F. Evidence for sex-specific risk alleles in autism spectrum disorder. Am J Hum Genet 2004; 75: 1117-1123.
135. Cantor R.M. Kono N. Duvall J.A. Alvarez-Retuerto A. Stone J.L. Alarcon M, Nelson S.F. & Geschwind D.H. Replication of autism linkage: Fine-mapping peak at 17q21. Am J Hum Genet 2005; 76:1050-1056.
136. Shao Y. Wolpert C.M. Raiford K.L. Menold M.M. Donnelly S.L. Ravan S.A. Bass M.P. McClain C. von Wendt L. Vance J.M. Abramson R.H. Wright H.H. Ashley-Koch A. Gilbert J.R. DeLong R.G. Cuccaro M.L. & Pericak-Vance M.A. Genomic screen and follow-up analysis for autistic disorder. Am J Med Genet 2002; 114: 99-105.
137. Rabionet R. Jaworski J.M. Ashley-Koch A.E. Martin E.R. Sutcliffe J.S. Haines J.L. DeLong G.R. Abramson R.K. Wright H.H. Cuccaro M.L. Gilbert J.R. & Pericak-Vance M.A. Analysis of the au-tism chromosome 2 linkage region: GAD1 and other candidate genes. Neuroscience Letters, 2004; 372: 209-214.
138. Devlin B. Bennett P. Dawson G. Figlewicz D.A. Grigorenko E.L. McMahon W. Minshew N. Pauls D. Smith M. Spence M.A. Rodier P.M. Stodgell C. The CPEA Genetics Network & Schellenberg G.D. Alleles of a Reelin CGG Repeat do not Convey Liability to Autism in a Sample From the CPEA Network. Am J Med Genet B Neuropsychiat Genet, 2004; 126B: 46-50.
139. Asherson P.J. & Collins S. Approaches to gene mapping in complex disorders and their application in child psychiatry and psychology. B J Psychiatry, 2001; 179: 122-128.
140. Jaenisch R. & Bird A. Epigenetic regulation of gene expresion: how the genome integrates intrinsic and environmental signals. Nature Genet Supp, 2003; 33: 245-254.
141. Shao Y. Raiford K.L. Wolpert C.M. Cope H.A. Ravan S.A. Ashley-Koch A.A. Abramson R.K. Wright H.H. DeLong R.G. Gilbert J.R. Cuccaro M.L. & Pericak-Vance M.A. Phenotypic homogeneity provides increased support for linkage on chromosome 2 in autistic disorder. Am J Hum Genet, 2002; 70: 1058-1061.
142. Kielinen M. Rantala H. Timonen E. Linna S-L. & Moilanen I. Associated medical disorders and disabilities in children with autistic disorder: A population-based study. Autism, 2004; 8: 49-60.
143. th 2006: doi:10.1073/pnas.0605296103
144. Beversdorf D.Q. Manning S.E. Hillier A. Anderson S.L. Nordgren R.E. Walters S.E. Nagaraja H.N. Cooley W.C. Gaelic S.E. & Bauman M.L. Timing of prenatal stressors and autism. J Autism Dev Disord, 2005;35: 471-478.
145. Wing L. & Potter D. The epidemiology of autistic spectrum disorders: is the prevalence rising ? Ment Retard Dev Disabil Res Rev. 2006; 8:151-161.
146. London E.A. The environment as an etiologic factor in autism: a new direction for research. Environ Health Perspect. 2000: 108 Suppl 3: 401-404.
147. Lawler C.P. Croen L.A. Grether J.K. & Van de Water J. Identifying environmental contributions to autism: provocative clues and false leads. Ment Retard Dev Disabil Res Rev. 2004; 10: 292-302.
148. Fischer L.J. Seegal R.F. Garney P.E. Pessah I.N. & Kodavanti P.R. Symposium Overview: toxicity of noncoplanar PCBs. Toxicol Sci, 1998; 41: 49-61.
149. Badawi N. Dixon G. Felix J.F. Keogh J.M. Petterson B. Stanley F.J. & Kurinczuk J.J. Autism following a history of newborn encephalopathy: more than a coincidence ? Dev Med Child Neurol, 2006; 48: 85-89.
150. Chauhan A. & Chauhan V. Oxidative stress in autism. Pathophysiology, 2006; 13: 171-181.
151. Chauhan A. Chauhan V. Brown W.T. & Cohen I. Oxidative stress in autism: Increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin - the antioxidant proteins. Life Sciences, 2004; 75: 2539-2549.
152. Rasalam A.D. Hailey H. Williams J.H. Moore S.J. Turnpenny P.D. Lloyd D.J. & Dean J.C. Characteristics of fetal anticonvulsant syndrome associated autistic disorder. Dev Med Child Neurol, 2005; 47: 551-555.
153. Miller M.T. Stromland K. Ventura L. Johansson M. Bandim J.M. Gillberg C. Autism associated with conditions characterized by developmental errors in early embryogenesis: a mini review. Int J Dev Neurosci, 2005; 23: 201-219.
154. Stromland K. Nordin V. Miller M. Akerstrom B. & Gillberg C. Autism in thalidomide embryopathy: a population study. Dev Med Child Neurol, 1994; 36: 351-356.
155. Libbey J.E. Sweeten T.L., McMahon W.M. & Fujinami R.S. Autistic disorder and viral infections. J Neurovir, 2005; 11: 1-10.
156. Sweeten T.L. Posey D.J. & McDougle C.J. Brief report: autistic disorder in three children with cytomegalovirus infection. J Aut Dev Disorders, 2004; 34: 583-586.
157. Ghaziuddin M. Bolyard B. & Alessi N. Autistic disorder in Noonan syndrome. J Intellect Disabil Res, 1994; 38: 67-72.
158. Ghaziuddin M. Al-Khouri I. & Ghaziuddin N. Autistic symptoms following herpes encephalitis. Eur Child Adolesc Psychiatry, 2002; 11: 1423-146.
159. Schmitt B. Seeger J. Kreuz W. Eneukel S. & Jacobi G. Central nervous system involvement of children with HIV infection. Dev Med Child Neurol, 1991; 33: 535-540.
160. Elia M. Bergonzi P. Ferri R. Musumeci S.A. Paladino A. Panerai S. & Ragusa R.M. The etiology of autism in a group of mentally retarded subjects. Brain Dysfunction, 1990; 3: 228-240.
161. Mouridsen S.E. Rich B. & Isager T. Psychiatric morbidity in dis-integrative psychosis and infan-tile autism: A long-term followup study. Psychopathology, 1999; 32: 177-183.
162. Levy S.E. & Hyman S.L. Novel Treatments for Autistic Spectrum Disorders. Ment Retard Dev Disabil Res Rev, 2005; 11: 131-142.
163. Pavone L. & Ruggieri M. The Problem of Alternative Therapies in Autism. Ch.9 pp172-200 in: M.Coleman (Ed.) The Neurology of Autism. 2005: Oxford University Press: Oxford.
164. MRC MRC Review of Autism Research: Epidemiology and Causes. 2001: Medical Re-search Council, London.
165. White J.F. Intestinal Pathophysiology in Autism. Exp Biol Med 2003: 228:639-649.
166. Jass J.R. The Intestinal Lesion of Autistic Spectrum Disorder. Eur J Gastroenterol Hepatol, 2005: 17: 821-822.
167. Whiteley P. Waring R. Williams L. Klovrza L. Nolan F. Smith S. Farrow M. Dodou K. Lough W.J. & Shattock P. Spot urinary creatinine excretion in pervasive developmental disorders. Pediatrics International, 2006; 48: 292-297.
168. Sykut-Cegielska J. Gradowska W. Mercimek-Mahmutoglu S. & Stockler-Ipsiroglu S. Biochemical and clinical characteristics of creatine deficiency syndromes. Acta Biochimica Polonica, 2004; 51: 875-882.
169. Nataf R. Skorupka C. Amet L. Lam A. Springbett A. & Lathe R. Porphyrinuria in childhood autistic disorder: implications for environmental toxicity. Toxicol Appl Pharmacol, 2006; 214: 99-108.
170. Hoshino Y. Yamamoto T. Kaneko M. & Kumashiro H. Plasma free tryptophan concentration in autistic children. Brain Dev, 1986; 8: 424-427.
171. McDougle C.J. Naylor S.T. Goodman W.K. Volkmar F.R. Cohen D.J. & Price L.H. Effects of tryptophan depletion in drug-free adults with autistic disorder. Arch Gen Psychiatry, 1996; 53: 993-1000.
172. Chugani D.C. Serotonin in autism and pediatric epilepsies. Mental Retardation and Developmental Disabilities Research Reviews, 2004; 10: 112-116.
173. Nabi R. Serajee F.J. Chugani D.C. Zhong H. & Huq A.H. Association of tryptophan 2,3 dioxygenase gene polymorphism with autism. Am J Med Genet B Neuropsychiatr Genet, 2004; 125: 63-68.
174. Coon H. Dunn D. Lainhart J. Miller J. Hamil C. Battaglia A. Tancredi R. Leppert M.F. Weiss R. & McMahon W. Possible association between autism and variants in the brain-expressed tryptophan hydroxylase gene (TPH2). Am J Med Genet B Neuropsychiatr Genet, 2005; 135: 42-46.
175. Kolevzon A. Mathewson K.A. & Hollander E. Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerability. J Clin Psychiatry, 2006; 6: 407-414.
176. Cox E.V. & White A.M. Methylmalonic acid excretion: index of vitamin B12 deficiency. Lancet, 1962: ii: 853.
177. Roze E. Gervais D. Demeret S. de Baulny H.O. Zittoun J. Benoist J-F. Said G. Pierrot-Deseilligny C. & Bolgert F. Neuropsychiatric Disturbances in Presumed Late-Onset Cobalamin C Disease, Arch Neurol, 2003; 60: 1457-1462.
178. Casella E.B. Valente M. de Navarro J.M. & Kok F. Vitamin B12 deficiency in infancy as a cause of developmental regression. Brain & Development, 2005; 27(8): 1-3
179. Cundiff D.K. & Harris W. Case report of 5 siblings: malnutrition ? Rickets ? DiGeorge syndrome ? Developmental Delay ? Nutrition Journal, 2006; 5: doi:10.1186/1475-2891-5-1
180. Dobson C.M. Wai T. Leclerc D. Kadir H. Narang M. Lerner-Ellis J.P. Hudson T.J. Rosenblatt D.S. & Gravel R.A. Identification of the gene responsible for the cblB complementation group of vitamin B12-dependent methylmalonic aciduria. Human Molecular Genetics, 2002; 11: 3361-3369.
181. Gräsbeck R. Imerslund-Gräsbeck syndrome (selective vitamin B12 malabsorption with proteinuria). Orphanet Journal of Rare Diseases, 2006;1:17 doi:10.1186/1750-1172-1-17
182. James S.J. Cutler P. Melnyk S. Jernigan S. Janak L. Gaylor D.W. & Neubrander J.A. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr, 2004; 80: 1611-1617.
183. James S.J. Melnyk S. Jernigan S. Cleves M.A. Halsted C.H. Wong D.H. Cutler P. Bock K. Boris M. Bradstreet J.J. Baker S.M. & Gaylor D.W. Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. Am J Med Genet B Neuropsychiatr Genet, 2006; doi 10. 1002 / amjg.b.30366
184. Clark-Taylor T. & Clark-Taylor B.E. Is autism a disorder of fatty acid metabolism? Possible dysfunction of mitochondrial beta-oxidation by long chain acyl-CoA dehydrogenase. Med Hypotheses, 2004; 62: 970-975.
185. Bell J.G. MacKinlay E.E. Dick J.R. MacDonald D.J. Boyle R.M. & Glen A.C. Essential fatty ac-ids and phospholipase A2 in autistic spectrum disorders. Prostaglandins Leukot Essent Fatty Acids, 2004; 71: 201-204.
186. Chauhan V. Chauhan A. Cohen I.L. Brown W.T. & Sheikh A. Alteration in amino-glycerophospholipids levels in the plasma of children with autism: A potential biochemical diagnostic marker. Life Sciences, 2004; 74: 1635-1643.
187. Amminger G.P., Berger G.E., Schafer M.R., Klier C., Friedrich M.H. & Feucht M. Omega-3 Fatty Acids Supplementation in Children with Autism: A Double-blind Randomized, Placebo-controlled Pilot Study. Biological Psychiatry, 2006; doi:10.1016/j.biopsych.2006.05.007
188. Kelley R.I. Inborn errors of cholesterol biosynthesis. Adv Pediatr, 2000; 47: 1-53.
189. Tierney E. Nwokoro N.A. Porter F.D. Freund L.S. Ghuman J.K. & Kelley R.I. Behavior phenotype in the RSH/Smith-Lemli-Opitz syndrome. Am J Med Genet, 2001; 98: 191-200.
190. Sikora D.M. Pettit-Kekel K. Penfield J. Merkens L.S. & Steiner, R.D. The near universal presence of autism spectrum disorders in children with Smith-Lemli-Opitz syndrome. Am J Med Genet A, 2006; 140: 1511-1518.
191. Tierney E. Bukelis I. Thompson R.E. Ahmed K. Aneja A. Kratz L. & Kelley R.I. Abnormalities of cholesterol metabolism in autism spectrum disorders. Am J Med Genet B Neuropsychiatr Genet, 2006; 141: 666-668.
192. Ming X. Stein T.P. Brimacombe M. Johnson W.G. Lambert G.H. & Wagner G.C Increased excretion of a lipid peroxidation biomarker in autism. Prostaglandins Leukot Essent Fatty Acids, 2005; 73: 379-384.
193. Ciara E. Popowska E. Piekutowska-Abramczuk D. Jurkiewicz D. Borucka-Mankiewicz M. Kowalski P. Goryluk-Kozakiewicz B. Nowaczyk M.J.M. & Krajewska-Walasek M. SLOS carrier frequency in Poland as determined by screening for Trp151X and Val326Leu DHCR7 mutations. Eur J Med Genet, 2006; doi:10.1016/j.emjg.2006.01.006
194. Wassif C.A. Zhu P. Kratz L. Krakowiak P.A. Battaile K.P. Weight F.F. Grinberg A. Steiner R.D. Nwokoro N.A. Kelley R.I. Stewart R.R. & Porter F.D. Biochemical, phenotypic and neurophysiological characterization of a genetic mouse model of RSH/Smith - Lemli - Opitz syndrome. Hum Mol Genet, 2001; 10: 555-564.
195. Waage-Baudet H. Lauder J.M. Dehart D.B. Kluckman K. Hiller S. Tint G.S. & Sulik K.K. Abnormal serotonergic development in a mouse model for the Smith-Lemli-Opitz syndrome: implications for autism. Int J Dev Neurosci, 2003; 21: 451-459.
196. Waage-Baudet H. Dunty W.C.Jr. Dehart D.B. Hiller S. & Sulik K.K. Immunohistochemical and microarray analyses of a mouse model for the smith-lemli-opitz syndrome. Dev Neurosci, 2005; 27: 378-396.
197. Rubenstein J.L.R. & Merzenich M.M. Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes, Brain and Behavior, 2003; 2: 255-267.
198. Carlson, N. R. Physiology of behavior (7th ed., pp. 96-129). 2001: Boston: Allyn and Bacon.
199. Vincent J.B. Horike S.I. Choufani S. Paterson A.D. Roberts W. Szatmari P. Weksberg R. Fernandez B. & Scherer S.W. An inversion inv(4)(p12-p15.3) in autistic siblings implicates the 4p GABA receptor gene cluster. J Med Genet, 2006; 43: 429-434.
200. Seragee F.J. Zhong H. Nabi R. & Mahbubul Huq A.H.M. The metabotropic glutamate receptor 8 gene at 7q31: partial duplication and possible association with autism. J Med Genet., 2003; 40: e42.
201. Fatemi, S.H. Halt, A.R. Stary, J.M. Kanodia, R. Schulz, S.C., & Realmuto, G.R. Glutamic acid decarboxylase 65 & 67 kDa proteins are reduced in autistic parietal & cerebellar cortices. Biological Psychiatry, 2002; 52: 805-810.
202. Kornhuber J. Mack-Burhardt, F. Konradi, C. Fritze, J. & Riderer, P. Effect of antemortem and postmortem factors on [3H]MK-801 binding in the human brain: Transient elevation during early childhood. Life Science, 1989; 45:745-749.
203. Shinohe A. Hashimoto K. Nakamura K. Tsujii M. Iwata Y. Tsuchiya K.J. Sekine Y. Suda S. Suzuki K. Sugihara G.I. Matsuzaki H. Minabe Y. Sugiyama T. Kawai M. Iyo M. Takei N. & Mori N. Increased serum levels of glutamate in adult patients with autism. Prog Neuropsychopharmacol Biol Psychiatry,2006: July 21st.
204. De Giacomo A. & Fombonne E. Parental recognition of developmental abnormalities in autism. Eur Child Adolesc Psychiatry, 1998; 7: 131-136.
205. Purcell A.E. Jeon O.H. Zimmerman A.W. Blue M.E. & Pevsner J. Postmortem brain abnormalities of the glutamate neurotransmitter system in autism. Neurology, 2001; 57:1618-1628.
206. Sodhi M.S. & Sanders-Bush E. Serotonin and Brain Development. Int Rev Neurobiol, 2004; 59: 111-174.
207. Attwell D. Brain Uptake of Glutamate: Food for Thought. J Nutr, 2000: 130: 1023S-1025S.
208. Abraham I. Juhasz G. Kekesi K.A. & Kovacs K.J. Corticosterone peak is responsible for stress-induced elevation of glutamate in the hippocampus. Stress, 1998: 2, 171-181.
209. Kandel, E.R. Schwartz, J.H., & Jessell, T. M. (Eds.) Principles of Neuroscience. 1991: New York: Elsevier.
210. King B.H. & Bostic J.Q. An update on pharmacologic treatments for autism spectrum disorders. Child Adolesc Psychiatr Clin N Am, 2006; 15: 161-175.
211. Hussman J. P. Suppressed GABAergic inhibition as a common factor in suspected etiologies of autism. J Aut Dev Disorders, 2001; 31, 247-248.
212. Tuchman R. & Rapin I. Epilepsy in autism. Lancet Neurology, 2002; 1: 352-358.
213. Gabis L. Pomeroy J. & Andriola M.R. Autism and epilepsy: Cause, consequence, comorbidity, or coincidence ? Epilepsy & Behavior, 2005; 7: 652-656.
214. Raymond G.V. Bauman M.L. & Kemper T.L. Hippocampus in autism: A Golgi analysis. Acta Neuropathol (Berl), 1996; 91: 117-119.
215. Kooy R.F. Willemsen R. & Oostra B.A. Fragile X syndrome at the turn of the century. Molecular Medicine Today, 2000; 6: 193-198.
216. Garber K. Smith K.T. Reines D. & Warren S.T. Transcription, translation and fragile X syn-drome. Current Opinion in Genetics and Development, 2006; 16: 270-275.
217. Fryns J.P. Borghgraef M. Brown T.W. Chelly J. Fisch G.S. Hamel B. Hanauer A. Lacombe D. Luo L. MacPherson J.N. Mandel J.L. Moraine C. Mulley J. Nelson D. Oostra B. Partington M. Ramakers G.J. Ropers H.H. Rousseau F. Schwartz C. Steinbach P. Stoll C. Tranebjaerg L. Turner G. Van Bokhoven H. & Vianna-Morgante A. 9th International Workshop on fragile-X syndrome and X-linked mental retardation. Am J Med Genet, 2000; 94: 345-360.
218. Crawford D.C. Acuna J.M. & Sherman S.L. FMR1 and the fragile X syndrome: human genome epidemiology review. Genet Med, 2001; 3: 359-371.
219. Crawford, D.C. Meadows K.L. Newman J.L. Taft L.F. Scott E. Leslie M. Shubek L. Holmgreen P. Yeargin-Allsopp M. Boyle C. & Sherman S.L. Prevalence of the fragile X syndrome in African-Americans. Am J Med Genet, 2002; 110: 226-233.
220. Tzeng C.C. Tsai L.P. Hwu W.L. Lin S.J. Chao M.C. Jong Y.J. Chu S.Y. Chao W.C. & Lu C.L. Prevalence of the FMR1 mutation in Taiwan assessed by large-scale screening of newborn boys and analysis of DXS548-FRAXAC1 haplotype. Am J Med Genet A, 2005; 133: 37-43.
221. Hatton D.D. Sideris J. Skinner M. Mankowski J. Bailey D.B. Jr. Roberts J. & Mirrett P. Autistic behavior in children with fragile X syndrome: Prevalence, stability, and the impact of FMRP. Am J Med Genet A, 2006; 140: 1804-1813.
222. Antar L.N. Afroz R. Dictenberg J.B. Carroll R.C. & Bassell G.J. Metabotropic Glutamate Receptor Activation Regulates Fragile X Mental Retardation Protein and Fmr1 mRNA Localization Differentially in Dendrites and Synapses. The Journal of Neuroscience, 2004; 24: 2648-2655.
223. Lopez-Bendito G. Shigemoto R. Fairen A. & Lujan R. Differential distribution of group 1 metabotropic glutamate receptors during rat cortical development. Cereb Cortex, 2002; 12: 625-638.
224. Gerevini V.D. Di Caruso A. Cappuccio I. Vitiani L.R. Romeo S. Della Rocca C. Gradini R. Melchiorri D. & Nicoletti F. The mGlu5 metabotropic glutamate receptor is expressed in zones of active neurogenesis of the embryonic and postnatal brain. Developmental Brain Research, 2004; 150: 17-22.
225. Romano C. Smout S. Miller J.K. & O'Malley K.L. Developmental regulation of metabotropic glutamate receptor 5b protein in rodent brain. Neuroscience, 2002; 111: 693-698.
226. Irwin S.A. Galvez R. & Greenough W.T. Dendritic spine structural anomalies in fragile-x mental retardation syndrome. Cereb Cortex, 2000; 10: 1038-1044.
227. Comery T.A. Harris J.B. Willems P.J. Oostra B.A. Irwin S.A. Weiler I.J. & Greenough W.T. Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proc Nat Acad Sci USA, 1997; 94: 5401-5404.
228. Kaufman W.E. & Moser H.W. Dendritic anomalies in disorders associated with mental retardation. Cerebral Cortex, 2000; 10: 981-991.
229. Ramackers G.J. Rho proteins, mental retardation and the cellular basis of cognition. Trends in Neurosciences, 2002; 25: 191-199.
230. Vanderklish P.W. & Edelman G.M. Differential Translation and fragile X Syndrome. Genes, Brain and Behavior, 2005; 4: 360-384.
231. Castre M. Lampinen K.E. Miettinen R. Koponen E. Sipola I. Bakker C.E. Oostra B.A. & Castre E. BDNF Regulates the Expression of Fragile X Mental Retardation Protein mRNA in the Hippocampus. Neurobiology of Disease, 2002; 11: 221-229.
232. Hagerman R.J. & Cronister A. Fragile X Syndrome: Diagnosis, Treatment and Research (2nd Edn.) 1996: Johns Hopkins Press: Baltimore.
233. Sutherland G.R. Gecz J. & Mulley J.C. Fragile X and other causes of x-linked mental retardation. in: D.I. Rimoin, J.M. O'Connor, R.E.Pyeritz & B.R.Korf (Eds.) Emery and Rimoin's Principles and Practice of Clinical Genetics. 2002; Churchill Livingstone: New York.
234. Kaufmann W.E. Cortell R. Kau A.S.I. Tierney E. Gray R.M. Cox C. Capone G.T. & Stanard, P. Autism spectrum disorder in fragile X syndrome: communication, social interaction, and specific behaviors. Am J Med Genet A, 2004: 129: 225-234.
235. Reddy K.S. Cytogenetic abnormalities and fragile-X syndrome in Autism Spectrum Disorder. BMC Med Genet, 2005; 6: 3.
236. Goodlin-Jones B.L. Tassone F. Gane L.W. & Hagerman R.J. Autistic spectrum disorder and the fragile X premutation. J Dev Behav Pediatr, 2004; 25: 392-398.
237. Miller G. Fragile X's Unwelcome Relative. Science, 2006:312: 518-521.
238. Jacquemont S. Hagerman R.J. Leehey M. Grigsby J. Zhang L. Brunberg J.A. Greco C. Des Portes V. Jardini T. Levine R. Berry-Kravis E. Brown W.T. Schaeffer S. Kissel J. Tassone F. & Hagerman P.J. Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates. Am J Hum Genet, 2003; 72: 869-878.
239. Hagerman R.J. Ono M.Y. & Hagerman P.J. Recent advances in fragile X: a model of autism and neurodegeneration. Current Opinion in Psychiatry, 2005; 18: 490-496.
240. Berry-Kravis E. Potanos K. Weinberg D. Zhou L. & Goetz C.G. Fragile X-associated tremor/ataxia syndrome in sisters related to X-inactivation. Ann Neurol. 2005; 57:144-147.
241. Chiurazzi P. Tabolacci E. & Neri G. X-linked mental retardation (XLMR): from clinical condition to cloned gene. Crit Rev Clin Lab Sci, 2004; 41: 117-158.
242. Sherman S.L. Premature ovarian failure in the fragile X syndrome. Am J Med Genet, 2000; 97: 189-194.
243. Welt C.K. Smith P.C. & Taylor A.E. Evidence of early ovarian aging in fragile X premutation carriers. J Clin Endocrinol Metab, 2004; 89: 4569-4574.
244. Steyaert J. Legius E. Borghgraef M. & Fryns J.P. A distinct neurocognitive phenotype in female fragile-X premutation carriers assessed with visual attention tasks. Am J Med Genet A, 2003; 116: 44-51.
245. Allen E.G. Sherman S. Abramowitz A. Leslie M. Novak G. Rusin M. Scott E. & Letz R. Examination of the effect of the polymorphic CGG repeat in the FMR1 gene on cognitive performance. Behav Genet, 2005; 35: 435-445.
246. Bear M.F. Therapeutic implications of the mGluR theory of fragile X mental retardation. Genes, Brain and Behavior, 2005; 10, doi: 10.1111/j.1601-183X.2005.00135.x
247. Bear M.F. Huber K.M. & Warren S.T. The mGluR theory of fragile X mental retardation. Trends in Neurosciences, 2004; 27: 370-377.
248. Frauli M. Neuville P. Vol C. Pin J-P. & Prezeau L. Among the twenty classical l-amino acids, only glutamate directly activates metabotropic glutamate receptors. Neuropharmacology, 2006; 50: 245-253.
249. Aschrafi A. Cunningham B.A., Edelman G.M. & Vanderklish P.W. The fragile X mental retardation protein and group 1 metabotropic glutamate receptors regulate levels of mRNA granules in brain. Proc Nat Acad Sci USA, 2005; 102: 2180-2185.
250. Bittigau P. & Ikonomidou C. Glutamate in neurologic diseases. Journal of Child Neurology, 1997; 12: 471-485.
251. Huber K.M. Gallagher S.M. Warren S.T. & Bear M.F. Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc Nat Acad Sci USA, 2002; 99: 7746-7750.
252. Koekkoek S.K.E. Yamaguchi K. Milojkovic B.A. Dortland B.R. Ruigrok T.J.H. Maex R. dr Graaf W. Smit A.E. VanderWerf F. Bakker C.E. Willemsen R. Ikeda T. Kakizawa S. Onodera K. Nelson D.L. Mientjes E. Joosten M. de Schutter E. Oostra B.A. Ito M. & de Zeeuw C.I. Deletion of FMR1 in Purkinje Cells Enhances Parallel Fiber LTD, Enlarges Spines, and Attenuates Cerebellar Eyelid Conditioning in Fragile X Syndrome. Neuron, 2005; 47: 339-352.
253. Greenough W.T. Klintsova A.Y. Irwin S.A. Galvez R. Bates K.E.& Weiler I.J. Synaptic regulation of protein synthesis and the fragile X protein. Proc Nat Acad Sci USA, 2001; 98: 7101-7106.
254. Malinow R. & Malenka R.C. AMPA receptor trafficking and synaptic plasticity. Ann Rev Neurosci, 2002; 25: 103-126.
255. Nishi A. Liu F. Matsuyama S. Hamada M. Higashi H. Nairn A.C. & Greengard P. Metabotropic mGlu5 receptors regulate adenosine A2A receptor signaling. PNAS, 2003; 100: 1322-1327.
256. Nishi A. Watanabe Y. Higashi H. Tanaka M. Nairn A.C. & Greengard P. Glutamate regulation of DARPP-32 phosphorylation in neostriatal neurons involves activation of multiple signaling cascades. PNAS, 2005; 102: 1199-1204.
257. Dolzhanskay N. Merz G. & Denman R.B. Oxidative stress reveals heterogeneity of FMRP granules in PC12 cell neurites . Brain Research, 2006; 1112: 56-64.
258. Gao F-B. Understanding Fragile X Syndrome: Insights from Retarded Flies. Neuron, 2002; 34: 859-862.
259. McBride S.M.J. Choi C.H. Wang Y. Leibelt D. Braunstein E. Ferreiro D. Sehgal A. Siwicki K.K. Dockendorf T.C. Nguyen H.T. McDonald T.V. & Jongens T.A. Pharmacological Rescue of Synaptic Plasticity, Courtship Behaviour, and Mushroom Body Defects in a Drosophila Model of Fragile X Syndrome. Neuron, 2005; 45: 753-764.
260. Dolen G. & Bear M.F. Courting a Cure for Fragile X. Neuron, 2005; 45: 642-644.
261. Yan Q.J. Rammal M. Tranfaglia M. & Bauchwirtz R.P. Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP. Neuropharmacology, 2005; 49: 1053-1066.
262. Simonyi A. Schachtman T.R. & Christoffersen G.R.J. The Role of Metabotropic Glutamate Receptor 5 in Learning and Memory. Drug News Perspect, 2005; 18: 353-361.
263. Nicoletti F. Bruno V. Copani A. Casabona G. & Knöpfel T. Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders ? TINS, 1996; 19: 267-271.